Mark Wade

715 total citations
24 papers, 478 citations indexed

About

Mark Wade is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mark Wade has authored 24 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Mark Wade's work include Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (4 papers) and Genomics and Chromatin Dynamics (4 papers). Mark Wade is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (4 papers) and Genomics and Chromatin Dynamics (4 papers). Mark Wade collaborates with scholars based in United Kingdom, United States and Spain. Mark Wade's co-authors include Dominic Jones, Luke Gaughan, Craig Robson, Jacqueline Stockley, Kelly Coffey, Laura Wilson, Daniel O’Neill, Sirintra Nakjang, M. H. Moore and Lynsey Rogerson and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Mark Wade

23 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Wade United Kingdom 12 326 140 89 72 56 24 478
Ivana Heřmanová Czechia 9 198 0.6× 97 0.7× 84 0.9× 52 0.7× 132 2.4× 16 406
Susan K. Rathe United States 12 234 0.7× 100 0.7× 84 0.9× 67 0.9× 87 1.6× 18 390
Camino Bermejo‐Rodríguez United Kingdom 11 223 0.7× 115 0.8× 68 0.8× 48 0.7× 30 0.5× 15 363
James A. Zanghi United States 10 441 1.4× 70 0.5× 53 0.6× 48 0.7× 101 1.8× 16 578
Francesco Bonetto United States 10 252 0.8× 205 1.5× 52 0.6× 24 0.3× 25 0.4× 14 426
Omer Gilan Australia 10 253 0.8× 93 0.7× 92 1.0× 28 0.4× 43 0.8× 13 362
Priya Chatterji United States 11 348 1.1× 209 1.5× 195 2.2× 23 0.3× 165 2.9× 16 590
Ran Yan United States 6 145 0.4× 173 1.2× 72 0.8× 38 0.5× 131 2.3× 8 378
Daneen Schaeffer United States 11 474 1.5× 128 0.9× 114 1.3× 91 1.3× 36 0.6× 14 633
Claire Mazumdar United States 4 241 0.7× 289 2.1× 90 1.0× 36 0.5× 316 5.6× 4 585

Countries citing papers authored by Mark Wade

Since Specialization
Citations

This map shows the geographic impact of Mark Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wade more than expected).

Fields of papers citing papers by Mark Wade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wade. The network helps show where Mark Wade may publish in the future.

Co-authorship network of co-authors of Mark Wade

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wade. A scholar is included among the top collaborators of Mark Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wade. Mark Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francis, Thomas, Eugenio Bringas, Inmaculada Ortíz, et al.. (2024). Environmental fluoxetine promotes skin cell proliferation and wound healing. Environmental Pollution. 362. 124952–124952.
2.
Felip, Enriqueta, Catherine A. Shu, Andrés Aguilar, et al.. (2024). 2MO Amivantamab plus chemotherapy vs chemotherapy as first-line treatment in EGFR exon 20 insertion-mutated advanced NSCLC: Analysis of post-progression endpoints from PAPILLON. ESMO Open. 9. 102581–102581. 1 indexed citations
3.
Iles, Alexander, et al.. (2023). A robust, flow-based, microfluidic device for siRNA-mediated gene knockdown in glioblastoma spheroids. Repository@Hull (Worktribe) (University of Hull). 10. 1 indexed citations
4.
Wade, Mark, et al.. (2023). The Use of Tissue-on-Chip Technology to Focus the Search for Extracellular Vesicle miRNA Biomarkers in Thyroid Disease. International Journal of Molecular Sciences. 25(1). 71–71. 4 indexed citations
5.
Moursi, Amr M., Alexander Iles, Katharina C. Wollenberg Valero, et al.. (2023). Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system. Lab on a Chip. 23(11). 2664–2682. 4 indexed citations
6.
7.
Drake, Charles G., Russell K. Pachynski, Sumit K. Subudhi, et al.. (2021). Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 25(2). 219–228. 28 indexed citations
8.
Brahmer, Julie R., Melissa L. Johnson, Manuel Cobo, et al.. (2020). JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies. JTO Clinical and Research Reports. 2(2). 100103–100103. 23 indexed citations
9.
Jones, Dominic, Laura Wilson, Huw D. Thomas, Luke Gaughan, & Mark Wade. (2019). The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer. Cancers. 11(8). 1122–1122. 18 indexed citations
10.
Welham, Kevin J., Martin Goddard, Yasir Abu-Omar, et al.. (2019). The inhibitory subunit of cardiac troponin (cTnI) is modified by arginine methylation in the human heart. International Journal of Cardiology. 282. 76–80. 12 indexed citations
11.
Brahmer, Julie R., Melissa L. Johnson, Manuel Cobo, et al.. (2019). Preliminary immunogenicity, safety, and efficacy of JNJ-64041757 (JNJ-757) in non-small cell lung cancer (NSCLC): Results from two phase 1 studies.. Journal of Clinical Oncology. 37(15_suppl). 9093–9093. 2 indexed citations
12.
Middleton, Fiona K., Miranda Patterson, Sarah Fordham, et al.. (2015). Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition. Oncotarget. 6(32). 32396–32409. 47 indexed citations
13.
Jones, Dominic, et al.. (2015). FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer. Oncotarget. 6(30). 29782–29794. 33 indexed citations
14.
O’Neill, Daniel, Dominic Jones, Mark Wade, et al.. (2015). Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget. 6(28). 26029–26040. 25 indexed citations
15.
Wade, Mark, et al.. (2015). Does radiation-induced c-MYC amplification initiate breast oncogenesis?. Molecular & Cellular Oncology. 3(1). e1010950–e1010950. 5 indexed citations
16.
Wade, Mark, Dominic Jones, Laura Wilson, et al.. (2014). The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Research. 43(1). 196–207. 77 indexed citations
17.
18.
Gaughan, Luke, Jacqueline Stockley, Kelly Coffey, et al.. (2013). KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade. Nucleic Acids Research. 41(14). 6892–6904. 66 indexed citations
19.
Al‐Balool, Haya H., David Weber, Yilei Liu, et al.. (2011). Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant. Genome Research. 21(11). 1788–1799. 37 indexed citations
20.
Gajra, Ajeet, et al.. (2007). Expression of the glutathione-S-transferase π (GST-π) protein correlates with survival in patients with stage I non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 21065–21065. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Heřmanová Breakdown of academic impact, for papers by Susan K. Rathe Breakdown of academic impact, for papers by Camino Bermejo‐Rodríguez Breakdown of academic impact, for papers by James A. Zanghi Breakdown of academic impact, for papers by Francesco Bonetto Breakdown of academic impact, for papers by Omer Gilan Breakdown of academic impact, for papers by Priya Chatterji Breakdown of academic impact, for papers by Ran Yan Breakdown of academic impact, for papers by Daneen Schaeffer Breakdown of academic impact, for papers by Claire Mazumdar
Rankless by CCL
2026